AI assistant
Sending…
ROX RESOURCES LIMITED — Director's Dealing 2015
Mar 3, 2015
65741_rns_2015-03-03_af10c5b0-b5a7-4fb2-9a20-ad9ffd29309f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Appendix 3Y
Change of Director’s Interest Notice
Name of entity: ROX RESOURCES LIMITED ABN: 53 107 202 602
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | JEFFREY GRESHAM |
|---|---|
| Date of last notice | 3 December 2013 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest | Held by The Gresham Superannuation fund of which Mr Gresham is a trustee and beneficiary. |
| Date of change | 2 March 2015 |
| No. of securities held prior to change | 2,528,251 |
| Class | Fully Paid Ordinary Shares |
| Number acquired | 500,000 |
| Number disposed | - |
| Value/Consideration | $13,946 |
| No. of securities held after change | 3,028,251 |
| Nature of change | On market purchase |
Part 2 – Change of director’s interests in contracts
NIL
Part 3 – Closed period
| Were the interests in the securities or contracts detailed above traded during a closed period where prior written clearance was required? |
No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? | N/A |
Appendix 3Y Page 1
More from ROX RESOURCES LIMITED
Share Issue/Capital Change
2026
May 27
Major Shareholding Notification
2026
May 21
Investor Presentation
2026
May 12
Capital/Financing Update
2026
May 6
Share Issue/Capital Change
2026
May 4
Director's Dealing
2026
May 4
Major Shareholding Notification
2026
Apr 26
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 20
Interim / Quarterly Report
2026
Apr 16